GKB Ophthalmics Ltd.

BSE: GKB533212ISIN INE265D01015

Healthcare
Medical Equipment & Supplies

Share price

₹62.00+3.40 (+5.80%)

as of 3 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹76.90
52W low: ₹45.25
Off 52W high: -19.38%
1M return: -3.12%
3M return: +8.91%
6M return: -1.85%
1Y return: -9.48%
20D avg volume: 892
50 DMA: ₹63.56
200 DMA: ₹60.70

Key ratios Consolidated

Market cap: ₹31.25 Cr
Current price: ₹62.00
52W high / low: ₹76.90 / ₹45.25
Face value: ₹10.00
P/E: 5.67
P/B: 0.59
EPS (TTM): ₹10.94
Book value / share: ₹104.82
ROE: —
ROCE: 9.60%
Operating margin: —
Net margin: —
Debt / equity: 0.21
Net debt: ₹8.98 Cr
Interest cover: 2.18
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 105.9 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24
Income statement
	33.04	29.79	56.79	30.17	32.31	31.02	25.80	26.14	26.02	—
	0.73	0.81	0.86	0.37	0.21	0.34	0.48	0.23	0.28	—
	33.77	30.60	57.65	30.54	32.52	31.36	26.29	26.37	26.30	—
	31.65	28.00	56.99	28.60	33.06	35.31	28.12	27.52	26.29	—
	4.92	4.62	3.62	5.43	6.63	6.46	4.33	5.22	5.14	—
	20.60	15.23	39.43	16.45	18.62	18.68	15.07	15.76	12.25	—
	3.60	3.32	3.92	4.37	4.80	4.54	4.29	4.39	4.04	—
	0.51	0.52	0.73	0.66	0.77	0.63	0.64	0.55	0.55	—
	0.80	0.80	0.82	0.82	0.80	0.80	0.77	0.77	0.76	—
	4.06	3.77	6.17	4.20	4.81	6.83	6.04	4.52	3.67	—
	2.12	2.60	0.67	1.94	-0.55	-3.95	-1.83	-1.15	0.01	—
	0.00	-1.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—
	2.12	1.11	0.67	1.94	-0.55	-3.95	-1.83	-1.15	0.01	—
	0.20	-0.04	-0.03	0.07	0.08	0.19	0.05	0.06	0.06	—
	1.85	1.12	0.71	1.84	-0.64	-4.13	-1.91	-1.15	0.10	—
	2.00	0.38	0.88	3.17	-2.02	-7.03	-4.03	-2.41	—	—
Key metrics
	3.43	2.43	2.22	3.42	1.02	-2.52	-0.42	0.17	1.32	—
	10.40%	8.20%	3.90%	11.30%	3.20%	-8.10%	-1.60%	0.70%	5.10%	—
	5.60%	3.80%	1.30%	6.10%	-2.00%	-13.30%	-7.40%	-4.40%	0.40%	—
	—	2.70%	—	4.10%	—	-5.30%	—	—	—	—
	2.30%	-4.00%	120.10%	15.40%	24.20%	—	—	—	—	—
	389.10%	127.10%	137.20%	260.00%	-740.00%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	149.79	149.06	108.99	—
	2.77	2.25	1.33	—
	152.56	151.31	110.32	—
	145.24	146.36	117.23	—
	18.59	20.30	21.15	—
	91.71	89.73	61.76	—
	15.21	16.11	17.26	—
	2.42	2.67	2.37	—
	3.24	3.24	3.09	—
	18.20	18.94	21.07	—
	7.33	4.95	-6.91	—
	-1.49	-1.79	0.00	—
	5.84	3.16	-6.91	—
	0.20	0.08	0.35	—
	5.52	3.03	-7.08	—
	6.43	2.42	-13.98	—
Key metrics
	11.50	9.07	-1.45	—
	7.68%	6.10%	-1.30%	—
	3.69%	2.00%	-6.50%	—
	—	9.60%	-7.20%	—
	29.95%	36.80%	—	—
	—	142.80%	—	—
	—	-4.84	-5.58	—
	—	-1.26	0.48	—
	—	0.21	0.26	—
	—	8.98	11.47	—
	—	105.9	122.5	—
Balance sheet
	—	132.17	125.21	—
	—	107.96	99.39	—
	—	2.67	3.02	—
	—	44.87	25.49	—
	—	54.63	50.38	—
	—	2.46	9.21	—
	—	14.82	17.03	—
	—	56.29	39.29	—
	—	71.19	62.39	—
	—	11.65	14.49	—
	—	10.08	11.41	—
	—	1.57	3.08	—
	—	54.89	56.44	—
Cash flow
	—	-3.81	-3.43	—
	—	9.00	2.55	—
	—	-5.55	0.67	—
	—	1.03	2.15	—

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24
Income statement
	6.40	6.40	4.36	6.11	8.78	8.43	7.45	8.26	8.62	—
	0.47	0.99	3.54	1.37	0.07	0.01	1.81	0.06	0.09	—
	6.87	7.39	7.90	7.47	8.85	8.44	9.26	8.31	8.71	—
	7.61	7.82	6.99	7.98	10.97	10.88	9.42	10.36	10.11	—
	3.29	2.86	1.72	2.98	5.13	4.81	4.17	5.04	4.87	—
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.04	0.02	—
	2.22	2.19	2.35	2.59	2.84	2.73	2.68	2.81	2.67	—
	0.30	0.32	0.60	0.57	0.68	0.60	0.48	0.40	0.41	—
	0.66	0.66	0.68	0.68	0.67	0.66	0.67	0.66	0.65	—
	1.34	1.43	1.04	1.51	1.74	1.85	1.56	1.84	1.63	—
	-0.74	-0.43	0.91	-0.51	-2.13	-2.44	-0.16	-2.04	-1.40	—
	0.00	-1.49	0.00	0.00	0.00	0.00	—	—	—	—
	-0.74	-1.93	0.91	-0.51	-2.13	-2.44	-0.16	-2.04	-1.40	—
	-0.24	-0.04	-0.07	0.02	0.02	0.04	0.01	0.01	0.01	—
	-0.50	-1.88	0.98	-0.52	-2.14	-2.48	-0.17	-2.05	-1.41	—
	-1.00	-3.74	1.95	-1.04	-4.25	-4.92	-0.33	-4.07	-2.80	—
Key metrics
	0.22	-0.95	2.19	0.74	-0.78	-1.18	0.99	-0.98	-0.34	—
	3.40%	-14.80%	50.20%	12.10%	-8.90%	-14.00%	13.30%	-11.90%	-3.90%	—
	-7.80%	-29.40%	22.50%	-8.50%	-24.40%	-29.40%	-2.30%	-24.80%	-16.40%	—
	—	-8.30%	—	0.30%	—	-6.70%	—	—	—	—
	-27.10%	-24.10%	-41.50%	-26.00%	1.90%	—	—	—	—	—
	76.60%	24.20%	676.50%	74.60%	-51.80%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	23.27	25.64	32.75	—
	6.37	5.97	1.97	—
	29.63	31.61	34.72	—
	30.40	33.47	40.76	—
	10.85	12.69	18.90	—
	0.00	0.00	0.07	—
	9.35	9.67	10.88	—
	1.79	2.17	1.89	—
	2.68	2.69	2.64	—
	5.32	5.72	6.88	—
	-0.77	-1.85	-6.04	—
	-1.49	-1.79	0.00	—
	-2.27	-3.65	-6.04	—
	-0.33	0.08	0.07	—
	-1.92	-3.57	-6.11	—
	-3.83	-7.08	-12.12	—
Key metrics
	2.20	1.21	-1.51	—
	9.45%	4.70%	-4.60%	—
	-8.25%	-13.90%	-18.70%	—
	—	-7.60%	-15.10%	—
	-29.31%	-21.70%	—	—
	—	41.60%	—	—
	—	-2.28	-6.47	—
	—	0.41	0.82	—
	—	0.67	1.02	—
	—	9.53	18.08	—
	—	75.7	73.5	—
Balance sheet
	—	36.60	49.49	—
	—	17.01	16.68	—
	—	0.00	0.00	—
	—	5.18	7.49	—
	—	5.18	6.08	—
	—	0.66	0.38	—
	—	12.49	14.44	—
	—	5.04	6.98	—
	—	17.18	22.08	—
	—	9.53	18.08	—
	—	8.51	10.83	—
	—	1.02	7.25	—
	—	14.33	17.67	—
Cash flow
	—	-1.48	-5.04	—
	—	12.21	-0.16	—
	—	-10.72	5.12	—
	—	0.80	1.43	—

Compounded growth

Standalone

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): -29.31%
Profit YoY (TTM): +71.93%

Consolidated

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): +29.95%
Profit YoY (TTM): +170.50%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 51.14%

Quarter	September 2026	June 2026
Promoter %	51.14%	51.14%

Holder	Type	Holding	Previous	Change
KRISHNA GOPAL GUPTA	Promoter	17.91%	17.91%	0.00%
VIKRAM GUPTA	Promoter	8.39%	8.39%	0.00%
GAURAV GUPTA	Promoter	8.09%	8.09%	0.00%
VEENA GUPTA	Promoter	5.97%	5.97%	0.00%
KRISHNA GOPAL GUPTA HUF	Promoter	5.97%	—	—
KRISHNA MURARI GUPTA	Public	5.54%	5.54%	0.00%
SHEFALI CHAWLA	Promoter	4.81%	4.81%	0.00%
TANVI JIGNESH MEHTA	Public	4.58%	4.82%	-0.24%
SOMO VISION CO. LTD.	Public	3.97%	3.97%	0.00%
BRIJENDRA KUMAR GUPTA	Public	3.31%	3.31%	0.00%
COEUS GLOBAL OPPORTUNITIES FUND	Public	1.79%	1.79%	0.00%
LALIT KUMAR GUPTA	Public	1.40%	1.40%	0.00%
JYOTIVARDHAN JAIPURIA	Public	1.32%	1.32%	0.00%
VARSHA CHUGH .	Public	1.27%	1.27%	0.00%
PHANI KISHORE TALLURI	Public	1.26%	1.26%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Poly Medicure Ltd	16,093	1,587.65	51.43	13.20%	+18.31% TTM	-12.49% TTM	-18.70%
MOLBIO DIAGNOSTICS LIMITED	15,901	1,379.80	—	—	—	—	—
Sahajanand Medical Technologies Limited	4,939	485.85	—	—	—	—	—
FISCHER MEDICAL VENTURES LIMITED	1,655	25.29	59.29	12.70%	+195.94% TTM	+371.52% TTM	-73.00%
Tarsons Products Limited	1,651	310.35	148.83	4.80%	+10.63% TTM	-59.68% TTM	+7.85%
Laxmi Dental Limited	1,036	188.30	31.98	11.50%	+13.07% TTM	+24.85% TTM	-40.71%
Hemant Surgical Industries Limited	884	608.10	—	19.50%	—	—	+109.69%
Fabtech Technologies Limited	591	133.05	16.61	11.60%	—	—	-44.16%
Prevest Denpro Limited	480	400.00	—	21.90%	—	—	-23.80%
Nureca Limited	288	301.65	60.46	3.40%	+33.66% TTM	+15.82% TTM	+17.10%
EARKART LIMITED S	161	117.00	32.59	12.10%	—	—	-48.46%
CHOKSI ASIA LIMITED S	120	210.00	23.08	18.40%	+21.40% TTM	+132.74% TTM	+97.28%
Shree Pacetronix Ltd	63	169.15	19.60	25.00%	+22.63% TTM	+208.57% TTM	-38.65%
Amkay Products Limited S	46	53.50	20.04	13.40%	—	—	+13.88%
KMS Medisurgi Limited S	44	132.80	177.07	4.80%	—	—	—
Royal Sense Limited	36	67.70	—	26.10%	—	—	-70.69%
GKB Ophthalmics Ltd.	31	62.00	5.67	9.60%	+29.95% TTM	+170.50% TTM	-9.48%
Centenial Surgical Suture Ltd. S	26	71.96	-17.99	2.60%	+6.70% TTM	+26.29% TTM	-33.37%
Transpact Enterprises Limited S	4	100.70	—	14.50%	—	—	-57.35%

Some figures use IPO-document inputs. Growth periods are shown per value; FY means annual.

Filings & corporate actions

Recent announcements

GKB Ophthalmics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 ,inter alia, to consider and approve the Unaudited Standalone and ....29 Oct 2026 · Board Meeting / Board Meeting
Please find herewith Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026.8 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to SEBI( Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, the " Trading Window" for dealing/ trading in the shares of the Company shall remain closed ....28 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to enclosed herewith a copy of the Minutes of the proceedings of the ....22 Sep 2026 · AGM/EGM / AGM
The 44th Annual General Meeting of the Company was held on August 25, 2026 at 11:00 A.M. ,at the registered office of the Company at 16-A, Tivim Industrial Estate, Mapusa Goa-403526. Pursuant ....26 Aug 2026 · AGM/EGM / AGM
The 44th Annual General Meeting of the Company was held today i.e Tuesday , August 25th, 2026, at 11.00 A. M., at the Registered Office of the Company at 16- A, Tivim Industrial Estate, ....25 Aug 2026 · AGM/EGM / AGM
Please find attached copies of newspaper cuttings of the extract of Statement of unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026, published in ....14 Aug 2026 · Company Update / Newspaper Publication
Enclosed please find the unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026. The above unaudited Financial Results and the Limited Review Reports ....12 Aug 2026 · Result / Financial Results
The meeting of the Board of Directors of the Company was held on August 12, 2026 which considered and took on record inter alia the unaudited Standalone and Consolidated Financial Results ....12 Aug 2026 · Board Meeting / Outcome of Board Meeting
Please find attached copies of newspaper cuttings of the Notice published in The Times of India (Goa Edition) dated August 01, 2026, Pudhari (Marathi) dated August 01, 2026, and Business ....1 Aug 2026 · Company Update / Newspaper Publication
Pursuant to Regulation 36(1) (b) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, the Company has sent a letter to those shareholders whose email addresses are ....31 Jul 2026 · Company Update / General
Pursuant to Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and Section 91 of the Companies Act 2013, read with Rule 10 of Companies (Management ....31 Jul 2026 · Corp. Action / Book Closure
Pursuant to Regulation 34 (1) (a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed please find a copy of the Annual Report along with the Notice of ....31 Jul 2026 · Others / Reg. 34 (1) Annual Report
GKB Ophthalmics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve the Standalone and Consolidated ....25 Jul 2026 · Board Meeting / Board Meeting
In continuation to intimation filed by the company on September 12, 2025 informing of the development in relation to the ongoing Litigation wherein an Award was passed by the Industrial ....14 Jul 2026 · Company Update / General
Please find herewith Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulation, 2018, for the quarter ended June 30, 2026. Kindly acknowledge the receipt of the same.7 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to provision of Regulation 7(2) read with Regulation 6(2) of SEBI ( Prohibition of Insider TRading ) Regulations, 2015 (PIT Regulation 2015) intimation be and is hereby given that ....30 Jun 2026 · Company Update / Code of Conduct under SEBI (PIT) Regulations, 2015
Pursuant to SEBI (Prohibition of Insider Trading ) Regulations 2015, as amended from time to time, The "Trading Window" for dealing /Trading in the shares of the Company shall remain closed ....26 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Please find enclosed copies of newspaper cuttings of the extract of statement of audited Standalone and Consolidated Financial Results for the year ended March 31, 2026, published in Free ....1 Jun 2026 · Company Update / Newspaper Publication
Enclosed please find the Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2026. Kindly take the information on record.27 May 2026 · Result / Financial Results
The meeting of the Board of Directors of the Company was held on May 27, 2026 which approved and took on record the Audited Standalone and Consolidated Financial Results of the Company ....27 May 2026 · Board Meeting / Outcome of Board Meeting
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that CRISIL Ratings Limited (" CRISIL Ratings") has migrated the ....27 May 2026 · Company Update / Credit Rating
Pursuant to Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, enclosed please find the Annual Secretarial Compliance Report for the year ended March ....23 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
GKB Ophthalmics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 ,inter alia, to consider and approve the Audited Standalone and ....4 May 2026 · Board Meeting / Board Meeting
Pursuant to Circular no. SEBI/HO/DDHS/CIR/P/2018/144, dated November 26,2018, issued by the securities and Exchange Board of India , we hereby confirm that GKB Ophthalmics Limited, is not ....7 Apr 2026 · Company Update / General
Please find herewith Certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations , 2018, for the quarter ended March 31, 2026. Kindly acknowledge receipt of the same.7 Apr 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find enclosed herewith the disclosure under Regulation 31 (4) of Securities and Exchange Board of India ( Substantial Acquisition of Shares and Takeover ) Regulation 2011 for the ....2 Apr 2026 · Company Update / General
Pursuant to SEBI (Prohibition of Insider Trading) Regulation 2015, as amended from time to time , the " Trading Window" for dealing / trading in the shares of the Company shall remain closed ....25 Mar 2026 · Insider Trading / SAST / Closure of Trading Window
A Seperate meeting of Independent Directors'' Meeting of the Company for the year 2025-26, was held, pursuant to Regulation 25(3) of SEBI (Listing Obligations and Disclosures Requirements) ....18 Mar 2026 · Company Update / General
Notice is hereby given that pursuant to Regulation 25 (3 & 4) of SEBI (Listing Obligations and Disclosures Requirements) Regulation, 2015, and Schedule IV, clause VII of the Companies Act, ....9 Mar 2026 · Company Update / General
Please find enclosed copies of newspaper cuttings of the extract of Statement of Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, ....14 Feb 2026 · Company Update / Newspaper Publication
Enclosed please find Unaudited Standalone and Consolidated Financial Results for the Quarter and nine months ended December 31, 202512 Feb 2026 · Result / Financial Results
The Meeting of the Board of Directors of the Company was held on February 12, 2026, which considered and took on record the Unaudited Standalone and Consolidated Financial Results of the ....12 Feb 2026 · Board Meeting / Outcome of Board Meeting
GKB Ophthalmics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 ,inter alia, to consider and approve the unaudited Standalone and ....30 Jan 2026 · Board Meeting / Board Meeting
We would like to inform you that the Statutory Auditor''s of the Company, MSKA & Associates, Chartered Accountants have intimated the Company that the Firm has converted itself into a Limited ....20 Jan 2026 · Company Update / General
Please find herewith Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulation, 2018 ,for the quarter ended December 31, 2025. Kindly acknowledge receipt of the same.8 Jan 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to provision of Regulation 7(2) read with Regulation 6(2) of SEBI(Prohibition of Insider Trading) Regulations, 2015 (PIT Regulations, 2015), intimation be and is hereby given ....30 Dec 2025 · Company Update / Code of Conduct under SEBI (PIT) Regulations, 2015
Pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015, as amended from time to time, the "Trading Window" for dealing/trading in the shares of the Company shall remain closed ....26 Dec 2025 · Insider Trading / SAST / Closure of Trading Window
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, enclosed please find the minutes of Postal Ballot of the Company. Kindly take the ....26 Nov 2025 · AGM/EGM / Postal Ballot
Pursuant to Regulation 30 , of SEBI(LODR) Regulation, 2015, we wish to inform you that the members of GSV Ophthalmics Private Limited of Material Subsidiary of the company at their Extraordinary ....21 Nov 2025 · Company Update / General

Board meetings

12 Nov 2026 Board Meeting - Financial Results
12 Aug 2026 Board Meeting - Financial Results